EORTC presents at the European Breast Cancer Conference (EBCC-11)
16 Mar 2018
In a few days time, the 11th edition of the European Breast Cancer Conference (EBCC-11) will begin in Barcelona (21-23 March 2018).
This conference will provide a unique multidisciplinary setting for health care professionals with a common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease landscape.
The aim of EBCC is to provide a European multidisciplinary platform for scientific exchanges on all aspects of breast cancer, from bench to bedside.
EORTC will welcome you on booth B2. We will be presenting results from two EORTC studies in the main plenary sessions:
- Trasutuzumab versus observation for high-risk, non-metastatic, HER2 non-amplified breast cancer with Circulating Tumor Cells (EORTC 90091-10093 Treat CTC): A European, multicenter, randomized phase 2 trial
Plenary Session: “Keynote Lecture, Best and Late Breaking Abstract Presentations”
Time: 21 March 2018 at 15:15
Authors: M. Ignatiadis, S. Litiere, F. Rothe, S. Riethdorf, C. Proudhon, T. Fehm, K. Aalders, H. Forstbauer, P. Fasching, E. Brain, P. Vuylsteke, E. Guardiola, R. Lorenz, K. Pantel, K. Tryfonidis, W. Janni, M. Piccart, C. Sotiriou, B. Rack, J.Y. Pierga
- Very low risk of locoregional breast cancer recurrence in the EORTC 10041/BIG 03-04 MINDACT trial: analysis of risk factors including the 70-gene signature.
Closing Plenary Session : “Keynote Lecture, Best and Late Breaking Abstract Presentations”
Time: 23 March 2018 at 15:05
Authors: E. Rutgers, K. Aalders, C. Poncet, F. Cardoso, J. Bogaerts, S. Delaloge, A. Thompson, K. Tryfonidis, L.J. van’t Veer, M. Piccart, I.T. Rubio for the MINDACT Investigators
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023